Nidovirales infectious disease
MONDO:0005876Infections with viruses of the order nidovirales. The concept includes arterivirus infections and coronaviridae infections.
Also known as: Nidovirales caused disease or disorder, Nidovirales disease or disorder
1001 clinical trials for this condition and its sub-types, 8 tagged with Nidovirales infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Nidovirales infectious disease
-
Coronaviridae infectious disease 11 trials · 998 incl. sub-types
1 sub-type
- Orthocoronavirinae infectious disease 30 trials · 997 incl. sub-types Sub-types →
-
Arterivirus infectious disease 0 trials
-
Torovirus infectious disease 0 trials
Most studied deeper sub-types
-
New hope for COVID-19 patients on ventilators: drug combo trial completed
Disease control CompletedThis study tested two drugs—remdesivir and aviptadil—in hospitalized COVID-19 patients with severe breathing failure. About 473 participants received either a study drug plus standard care or a placebo plus standard care. The goal was to see if these drugs could safely improve ou…
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Remdesivir put to the test in COVID-19 patients on oxygen
Disease control CompletedThis completed Phase 3 trial tested the safety and effectiveness of remdesivir in 87 hospitalized COVID-19 patients with acute respiratory distress syndrome (severe breathing failure). Participants received either remdesivir plus standard care or a placebo plus standard care for …
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Experimental drug aviptadil tested in COVID-19 lung crisis
Disease control CompletedThis phase 3 trial tested whether the drug aviptadil can help hospitalized COVID-19 patients with acute respiratory distress syndrome (ARDS). 471 participants received either aviptadil plus standard care or a placebo plus standard care. The main goal was to see how well patients …
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Nerve block may fix COVID smell problems, study says
Symptom relief CompletedThis study tested whether a stellate ganglion block (an injection near nerves in the neck) can improve distorted sense of smell (parosmia) caused by COVID-19. 48 adults with long-term smell issues after COVID took part. Half received the nerve block, half got a placebo (saline). …
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC